Stanton L. Young Excellence in Research Award//Internal Announcement
For more than 40 years, the University of Oklahoma College of Medicine has presented the Stanton L. Young Master Teacher Award to a truly inspiring teacher, one who goes beyond excellence in conveying knowledge, touching lives and changing attitudes. The deadline for nominations is March 15, 2025.
Fo additional information see the attached document.
College of Medicine Alumni Association (COMAA) - COMAA awards are important resources for funding basic and clinical research projects of new and early-stage investigators in the College of Medicine. The guidelines are included with this notice attached. Deadline is Wednesday, March 26, 2025 at 5:00PM.
Please find attached the Guidelines for the SCC NACCHE ICON 2025 - Trainee Travel Awards.
The Stephenson Cancer Center (SCC) Native American Center for Cancer Center Health Excellence (NACCHE) is soliciting applications for its 2025 Trainee Travel Awards. The goal of this program is to support trainees to for travel costs to present abstracts at a health or public health related meeting.
Applicants must be majoring or working in a field of study related to understanding and addressing cancer prevention and control in Native American persons and their communities and enrolled at OUHSC, OU Norman, or OU Tulsa. These awards are available to:
Junior or senior undergraduates ages 18 or older, Graduate students, Professional students enrolled, Medical students, Clinical residents training, Clinical fellows training, Postdoctoral fellows, Full-time faculty enrolled in a graduate or professional degree program, Other academic institutions, Tribal Nations, or tribal entities involved in the Improving Cancer Outcomes in Native American Communities (ICON) grant.
Up to $1,250 will be awarded per applicant to support the registration fees, airfare, hotel or other related expenses. These and other qualifying expenses will be reimbursed per the University of Oklahoma’s Travel Reimbursement policy. No indirect costs are allowed.
OPEN DEADLINE: Applications will be received and reviewed on a rolling deadline. The number of awards made each year will be determined by the available amount of funding and the quality of applications. Awardees will be notified within 15 days of submitting an application. Please submit your application in a single PDF file to
NACCHE@ou.edu If you have any questions or concerns, please reach out to
NACCHE@ou.edu.
Presbyterian Health Foundation (PHF) Bridge Grant Program – Request for Applications
The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques. This program provides funding for up to
$75,000 for one year. Guidelines and Application Form are attached or can be found at
https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email
Kathy-Kyler@ouhsc.edu.
Presbyterian Health Foundation (PHF) Clinician Scientist Development Grant Program Year 1 – Request for Applications
The primary objective of the PHF Clinician Scientist Development Grant Program is to provide funding to a new or early-stage clinician scientist faculty member. This award is designed to support the applicant’s clinical and/or translational research project and to assist him or her with advancing this research project to a level that will be competitive for funding through a federal career development award mechanism. This program can provide funding for up to two years. The second year of funding will be based on successful achievement of identified milestones, completion of an application for Year Two funds, and whether funds are available.
The Principal Investigator must be an OUHSC primary faculty member with appointment at OUHSC as an Assistant Professor. Fellows are permitted to apply with a letter from their department chair guaranteeing the fellow will hold a faculty position that is not dependent on receipt of the grant at the award start date. New or early-stage clinical scientist faculty members with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to
ORA4PHF@ouhsc.edu). Guidelines and Application Form are attached or can be found at
https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email
Kathy-Kyler@ouhsc.edu.
Presbyterian Health Foundation (PHF) Seed Grant Program – Request For ApplicationsCycle II
PHF Seed Grant Program Deadline: March 12, 2025
The primary objective of the PHF Seed Grant program is to provide a one-year grant for new OUHSC investigators to initiate research programs. Secondary objectives are to provide established OUHSC faculty with the opportunity to initiate new unfunded projects and to provide unfunded OUHSC faculty funds to initiate a research program. Applications from new investigators (within 5 years of first full academic appointment and never having received independent federal funds) are given special consideration during peer review and at the time of funding consideration. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to
ORA4PHF@ouhsc.edu.
Presbyterian Health Foundation (PHF) Clinical Translational Grant Award (CTGA) Program – Request For Applications
The CTGA program replaces the Team Science program. The primary objective of this PHF CTGA mechanism is to grow collaborations and expand innovative healthcare research activities and promote collaboration among faculty to help OUHSC achieve the goals outlined in Pillar 1 of the Strategic Plan. The investigators must consist of one basic science researcher and one clinician researcher who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of a basic science researcher, a clinician researcher, and their respective expertise and/or disciplines. It is expected that both members of the investigator team will devote an equivalent amount of effort to the project (60/40 or 50/50 distribution of effort).
The funding for this program can be for up to two years. The second year of funding, if funds are available, will be based on successful achievement of identified milestones as noted by the researchers in the Year 1 application and quality of specified milestones to be met during the next year of funding, as documented in the completed Year Two application form.
This funding opportunity is intended to:
-
Promote collaborative scientific interactions among investigators
-
Support translation of novel basic/pre-clinical observations or the translation, dissemination, and implementation of clinical observations to community settings
-
Foster engagement of interdisciplinary teams
-
Support collaborative interactions among clinical and fundamental research investigators leading to co-authored papers and grant applications.
PHF CTGA awardees may hold PHF Symposium grants, Technology Advancement Grants (TAG), or Bridge grants throughout the duration of this award, but may not serve as the Contact PI/Team Leader on more than one PHF Clinical Translational Grant. A single investigator may only be awarded one CTGA award at a time, whether as contact PI or collaborating PI.
Presbyterian Health Foundation (PHF) Technology Advancement Grant (TAG) Program – Request For Applications
Cycles I-III PHF TAG Grant Program Deadline: ROLLING APPLICATIONS
The TAG program replaces the Equipment grant program. The primary objective of the PHF TAG program is to provide partial funding for critically needed research equipment that could be transformative for the research mission at OUHSC. This program is fully aligned with Pillar 1 of the Strategic Plan. The TAG program will proactively and with the help of a committee address campus-wide needs and fill critical gaps, with the goals to grow the research enterprise, expand innovative technology and research infrastructure, and promote addition of new cutting-edge technology on campus. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. Funds may be used for equipment to be purchased as part of a recruitment package for new faculty or for equipment to support the research of current faculty. If the funds will be used for a new recruit, the recruit must have signed the offer letter with a specific start date or specific start date time frame. Equipment and/or technology funded by PHF is expected to be made available to all researchers at OUHSC, whenever possible. All OUHSC Assistant, Associate, or Full Professors are eligible to apply. Applicants are required to match requested funds. The maximum allowable budget for this program is $500,000 (PHF funding: $250,000; Applicant funding: $250,000). The minimum allowable budget for this program is $60,000 (PHF funding: $30,000; Applicant funding: $30,000). Only one application will be accepted per investigator per year.
New Clinical Study Opportunities
***************************************************
Please note this is NOT a solicitation for study subjects
***************************************************
Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:
-
VEXAS clinical study – Novartis
-
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs),
-
MS
-
Sjogren’s Disease
-
Breast Cancer
-
mCRPC (Metastatic Castrate Resistant Prostate Cancer
-
mHSPC (Metastatic Hormone Resistant Prostate Cancer)
-
Pfizer - Request for Proposals (RFP) Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research. The intent of this RFP is to support non-interventional Investigator Sponsored Research projects that will advance the understanding of IB6 patterns of expression and clinical outcomes in NSCLC or explore sigvotatug vedotin’s preclinical activity. Due Date: March 20, 2025.
Please contact Scott Davis at
scott-davis@ouhsc.edu if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.